ClinicalTrials.gov
ClinicalTrials.gov Menu

RAS Quantification in Patients With Aliskiren or Candesartan (RASQAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01827202
Recruitment Status : Completed
First Posted : April 9, 2013
Last Update Posted : March 16, 2016
Sponsor:
Information provided by (Responsible Party):
Marcus Saemann, Medical University of Vienna

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2016
  Actual Study Completion Date : February 2016